|
2002
Joint Meeting with Association of British Neurologists
|
Final Program
held at
Royal College of Physicians, London. October 2nd-4th 2002
CLICK HERE FOR A REGISTRATION FORM - WORD FORMAT or PDF
CLICK HERE FOR THE FULL PROGRAM - WORD FORMAT or PDF
Programme in brief (see below for full program)
Wednesday 2nd October 2002
am ABN Subcommittee meetings
1200 onwards Registration
1230 Association of British Neurology Trainees business meeting (Wolfson Theatre)
1300 Lunch
1400 Educational Symposium: Neurodegeneration and Dementia
1545 Tea and Exhibition
1735 End of session
Refreshments
1800 Satellite Symposium: Issues in the management of chronic epilepsy
sponsored by UCB Pharma
1915 End of Satellite Symposium, followed by Dinner arranged by UCB Pharma
Thursday 3 October 2002
0800 Registration
0900 Scientific session
Morning Symposium: Neurological unexplained symptoms
1030 Coffee and Exhibition
1115 Scientific session
1230 Poster Session
Lunch and exhibition
1430 Scientific Session
Afternoon Symposium: Frontal Lobes
1600 Tea and exhibition
1630 Scientific Session
1715 Guest Lecture
1800 End of session
1930 for 2000 Reception and Dinner, Royal College of Surgeons, London
Friday 4 October 2002
0800 Registration
0900 Scientific Session
1000 Coffee, Posters and Exhibition
1036 Scientific Session
1215 Presentation of ABN Medal
Medallist's Lecture
1300 Lunch and Exhibition
1400 Scientific Session
1448 Tea and Exhibition
1520 Debate
1630 End of meeting
FULL PROGRAM (Word 97 version, pdf version )
Wednesday 2 October 2002
1200 on Registration
1230 Association of British Neurology Trainees
business meeting
Wolfson Theatre
1300 Lunch
Afternoon Session 1 Educational Symposium
organised by St Mary's Hospital
Neurodegeneration and Dementia
Chairman: Professor MN Rossor
1400 Cerebral vasculitis
Professor N Scolding, Bristol
1440 Dementia with Lewy Bodies
Dr I McKeith
1520 1. The clinical and behavioural correlates of right temporal lobe atrophy
D Chan
1532 2. Diagnosis of dementing diseases
using magnetic resonance imaging:
impact of ventricular and extraventricular CSF measurements
C Beeston
1545 Tea & Exhibition
1615 Clinical features of vCJD
Professor R Will
1655 Molecular pathology of vCJD
Professor J Collinge
1735 End of session
Afternoon Session 2 Satellite Symposium sponsored by UCB Pharma
Issues in the management of chronic epilepsy
Chairman: Dr PEM Smith
1800 Early recognition and management of
refractory epilepsy:
have we made any progress?
Dr SJ Wroe
1835 Chronic Epilepsy: not a benign condition
- epilepsy related death
Professor JWAS Sander
1915 End of satellite symposium
Dinner arranged by UCB Pharma
Thursday 3 October 2002
Morning Session Symposium: Neurological unexplained symptoms
Chairmen: BNPA: Dr J Mellers (tbc)
ABN: Dr SF Farmer
0900 Amnesias
Professor M Kopelman
0930 Pseudoseizures
Professor M Trimble
1000 Psychogenic dystonias
Dr A Schrag
1030 Coffee & exhibition
1115 Controversies and management
Dr M Sharpe
1145 Panel Discussion: Neither Neurologists
nor Psychiatrists are competent to manage conversion disorder
Chairman: Dr T Griffiths
Discussants: Dr D Bateman, Professor M Kopelman, Dr A Schrag, Dr M Sharpe, Professor
M Trimble, Dr D Wade and Dr A Zeman
1230-1430 Poster Session
Lunch & exhibition
Afternoon Session Frontal Lobes
Chairmen: BNPA: Professor R Dolan (tbc)
ABN: Dr J Chataway
1430 Neuropsychology
Professor T Robbins
1500 Frontal dementia
Professor D Neary
1530 Frontal lobology
Professor A David
1600 Tea & exhibition
1630 Video session and discussion
Professor MN Rossor
1715-1800 Guest Lecture
Politician's Health
The Rt Hon the Lord Owen CH
Followed by questions and answers
1930 for 2000 Reception and Dinner at the
Royal College of Surgeons, Lincoln's Inn Fields
(business suit)
Friday 4 October 2002
Morning Session 1 Dementia and Parkinson's
Disease
Chairman: Dr SF Farmer
0900 3. The accuracy of the pulvinar sign
on MRI in the diagnosis of variant
Creutzfeldt-Jakob disease
D Collie
0912 4. The first hundred cases of vCJD:
early psychiatric and neurological features
and retrospective diagnostic evaluation
M Spencer
0924 5. Neuropsychiatric systemic lupus
erythematosus
F Joseph
0936 6. Cognitive and behavioural profile
of atypical Parkinsonian syndromes
T Bak
0948 7. A Yorkshire kindred with young onset
atypical PSP and central hypoventilation
due to a novel homozygous S352L tau mutation
D Nicholl
1000 Coffee, Posters and Exhibition
Morning Session 2 Multiple Sclerosis, Epilepsy
& Psychiatry
Chairman: Professor AJ Thompson
1036 8. The effective of nathalizumab and
MRI outcome measures in patients with
relapsing multiple sclerosis
C Dalton
1048 9. Cortical multiple sclerosis
M Zarei
1100 10. Genetic analysis of multiple sclerosis
in Europeans (GAMES)
DAS Compston
1112 11. Corticosteroids do not prevent
optic nerve atrophy following optic neuritis
S Hickman
1124 12. The 12 year prognosis of unilateral
functional weakness and sensory disturbance
J Stone
1136 13. The relationship between treatment
with Valproate, Lamotrigine and Topiramate
and the prognosis of the idiopathic generalised epilepsies
A Nicholson
1148 14. Longer-term outcome in children
born to mothers with epilepsy
N Adab
1200 15. A study of déjà vu
in patients with temporal lobe epilepsy, students and
neurology outpatients
C Warren-Gash
1215 Award of the ABN Medal
Medallist's Lecture
1300 Lunch & exhibition
Afternoon Session 1 Stroke
Chairman: Professor CP Warlow
1400 16. Predicting prolonged dysphagia
following acute stroke
S Broadley
1412 17. Homocysteine and cerebral small
vessel disease: a potential disease
mechanism through endothelial dysfunction
A Hassan
1424 18. Can outpatient neurology services
ever provide sufficiently rapid assessment of
TIA and minor stroke?
E Flossmann
1436 19. Ambulatory transcranial doppler
monitoring for circulating asymptomatic cerebral
emboli
A Mackinnon
1448-1520 Tea
Afternoon Session 2
Chairman: Dr DJ Thomas
1520 Debate: Published trials do not provide sufficient evidence to warrant the use of aspirin for the secondary prevention of ischaemic stroke.
Proposed by: Professor J Cleland, Professor
of Cardiology, Hull University
Opposed by: Dr C Sudlow, Anti-Thrombotic Trialists Collaboration, Oxford
1630 End of meeting
--------------------------------------------------------------------------------------------------------------------------------------------
POSTERS
Session Time: THURSDAY 3 OCTOBER 2002
1330 - 1430 hrs
Topic: CVA
P1 The role of endothelial dysfunction in
lacunar infarction and ischaemic leukoaraiosis
A Hassan
P2 A study of impaired awareness due to
stroke
J Louis-Auguste
P3 High early risk of stroke after a first
transient ischaemic attack
J Lovett
P4 A spatial memory deficit exacerbates
visual neglect following stroke
P Malhotra
P5 Diffusion tensor MRI provides independent
markers of cognitive dysfunction in ischaemic leukoaraiosis
M O'Sullivan
Topic: DEMENTIA
P6 Diagnosis of sporadic CJD using the putamen
intensity gradient
A Colchester
P7 Cognitive dysfunction after isolated brainstem insult: an underdiagnosed
cause of long-term morbidity
P Garrard
P8 Probabalistic diagnostic classification
of dementing diseases using an automated analysis of the distribution and severity
of cerebral atrophy
A Jackson
P9 Do rates of cerebral atrophy in Alzheimer's
disease accelerate?
J Janssen
P10 Does MRI/MRS permit ante mortem diagnosis
of progressive subcortical gliosis of Neumann?
A Larner
P11 Presenting features in frontotemporal
dementia: distinct cognitive and behavioural profiles in the left and right
temporal lobe variants
S Thompson
P12 Patterns of neuropsychological deficits
in vascular, Alzheimer's and frontotemporal dementias
A Varma
P13 Variant Creutzfeldt Jakob Disease: an
epidemiological update in relation to geographically associated cases and history
of vaccination
H Ward
P14 Variant CJD: development of a national
coordinated care programme
B Weller
Topic: EPILEPSY
P15 Use of short term video EEG in the diagnosis
of attack disorders
A McGonigal
P16 Percutaneous stereotactic thermocoagulation
of hypothalamic hamartomas: efficacy and safety
N Mullatti
P17 Prospective analysis of the outcome
of levetiracetam treatment
D Smith
P18 How accurate are seizure descriptions?
U Wieshmann
Topic: MISCELLANEOUS
P19 Charles Karsner Mills (1845-1931) and
his syndrome
C Carroll
P20 Hypocretin (Orexin) in neurological,
sleep and psychiatric disorders: a prospective study of CSF hypocretin
I Ebrahim
P21 Nociceptin/orphanin FQ, an ORL-1(NOP1)
agonist inhibits trigeminovascular activation in the rat
P Goadsby
P22 Screening of the spastin gene in autosomal
dominant hereditary spastic paraplegia reveals 7 novel mutations
C Proukakis
P23 The effect of corticosteroid on conduction
in the visual pathways. A serial study using visual psychophysics
E Pye
P24 Volumetric registration of low-grade
gliomas: a quantitative approach to measuring tumour
J Rees
P25 [11C]-WAY100635 PET: a surrogate marker
for MND?
M Turner
Topic: MULTIPLE SCLEROSIS
P26 CAMPATH-1H in the treatment of patients
with worsening multiple sclerosis
A Cox
P27 Aggregate cultures from adult human
brain are a source of oligodendrocyte lineage cells
C Halfpenny
P28 Genetic susceptibility to multiple sclerosis:
an analysis of four candidate genes
A Hensiek
P29 Influence of depression on self-reporting
of the physical impact of multiple sclerosis in two community-based populations
C McGuigan
P30 Treatment with beta interferon treatment
in multiple sclerosis downregulates survivin expression in T lymphocytes
M Sharief
P31 Multiple sclerosis and occult gluten
sensitivity
C Tengah
Topic: PARKINSON'S DISEASE
P32 Failure to identify change in the cervical
dystonia muscle pattern is the main cause of reduced response to BTXA
C Cordivari
P33 Clinical phenotypes in PD and the development
of dementia
E Dunn
P34 The neural basis for cognitive heterogeneity
in Parkinson's disease as determined by fMRI
S Lewis
P35 Study of mutant and wild type torsinA
in human SH-SY5Y cell lines
A Misbahuddin
P36 Early limb-onset dystonia with late
generalisation in an Irish family in which the DYT1 (TORIA) GAG deletion has
been excluded
S O'Riordan
P37 Picturing the atrophy patterns of progressive
supranuclear palsy and multiple system atrophy in vivo using fluid-registered
MRI
J Schott
Topic: PERIPHERAL NEUROPATHY
P38 Preferential expression of insulin-like
growth factor 1 (IGF-1) and receptor (IGF-1R) in small dorsal root ganglion
neurons and downregulation within two models of nerve injury
M Craner
P39 Abnormal oscillatory drive to motorneurones
in Kallman's syndrome
S Farmer
P40 Peripheral nerve granuloma in a patient with tuberculosis
R Orrell